Publication | Open Access

The immunosuppressant FK506 promotes development of the chondrogenic phenotype in human synovial stromal cells via modulation of the Smad signaling pathway

InflammationChondrogenic PhenotypeSclerostinDevelopmental BiologySignal TransductionBone Morphogenic ProteinSignaling PathwayOsteoarthritisMedicineCell BiologyCell SignalingImmunosuppressant Fk506